$77.7 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$1.55 BillionTotal revenue in the last quarter.
$377 MillionNet income is all revenues minus all expenses including taxes and interest in the last quarter.
$3.39Earnings per share is the amount of net income that is attributed to each single share outstanding.
$0.764 (0.47%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
48.16xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$553 MillionEarnings before interest expenses and taxes in the last quarter.
10,600The number of full time employees.
Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis to participate in the Credit Suisse Virtual Healthcare Conference on Nov. 10.Business Wire, 2 days ago
This report provides in-depth study on the current state of the Global Livestock Animal Vaccine Market 2020-2025. Key players in the Global Livestock Animal Vaccine Market have been identified thro...OpenPR, 5 days ago
Teesside comic Roy Chubby Brown's money will help provide care for poorly babiesTeesside Live, 7 days ago